Search Results - "Tolwani, Ashita J."

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury by Palevsky, Paul M., MD, Liu, Kathleen D., MD, PhD, Brophy, Patrick D., MD, Chawla, Lakhmir S., MD, Parikh, Chirag R., MD, PhD, Thakar, Charuhas V., MD, Tolwani, Ashita J., MD, Waikar, Sushrut S., MD, Weisbord, Steven D., MD

“…In response to the recently released 2012 KDIGO (Kidney Disease: Improving Global Outcomes) clinical practice guideline for acute kidney injury (AKI), the…”
Get full text

A Prospective International Multicenter Study of AKI in the Intensive Care Unit by Bouchard, Josée, Acharya, Anjali, Cerda, Jorge, Maccariello, Elizabeth R, Madarasu, Rajasekara Chakravarthi, Tolwani, Ashita J, Liang, Xinling, Fu, Ping, Liu, Zhi-Hong, Mehta, Ravindra L

“…AKI is frequent and is associated with poor outcomes. There is limited information on the epidemiology of AKI worldwide. This study compared patients with AKI…”
Get full text

Acute kidney injury in neurocritical care by Husain-Syed, Faeq, Takeuchi, Tomonori, Neyra, Javier A, Ramírez-Guerrero, Gonzalo, Rosner, Mitchell H, Ronco, Claudio, Tolwani, Ashita J

“…Approximately 20% of patients with acute brain injury (ABI) also experience acute kidney injury (AKI), which worsens their outcomes. The metabolic and…”
Get full text

Outcomes of critically ill children requiring continuous renal replacement therapy by Hayes, Leslie W., MD, Oster, Robert A., PhD, Tofil, Nancy M., MD, Tolwani, Ashita J., MD, MS

“…Abstract Purpose Acute kidney injury in the pediatric intensive care unit (PICU) is associated with significant morbidity, with continued mortality greater…”
Get full text

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury by Tumlin, James A, Galphin, Claude M, Tolwani, Ashita J, Chan, Micah R, Vijayan, Anitha, Finkel, Kevin, Szamosfalvi, Balazs, Dev, Devasmita, DaSilva, J Ricardo, Astor, Brad C, Yevzlin, Alexander S, Humes, H David

“…Acute kidney injury (AKI) is a highly morbid condition in critically ill patients that is associated with high mortality. Previous clinical studies have…”
Get full text

Efficacy and Safety of Renal Tubule Cell Therapy for Acute Renal Failure by TUMLIN, James, WALI, Ravinder, FINKEL, Kevin W, KRAUS, Michael A, HUMES, H. David, WILLIAMS, Winfred, MURRAY, Patrick, TOLWANI, Ashita J, VINNIKOVA, Anna K, SZERLIP, Harold M, JIUMING YE, PAGANINI, Emil P, DWORKIN, Lance

“…The mortality rate for patients with acute renal failure (ARF) remains unacceptably high. Although dialysis removes waste products and corrects fluid…”
Get full text

Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 Patients Treated with Concomitant CRRT by Bauer, Seth R, Salem, Charbel, Connor, Jr, Michael J, Groszek, Joseph, Taylor, Maria E, Wei, Peilin, Tolwani, Ashita J, Fissell, William H

“…Current recommendations for piperacillin-tazobactam dosing in patients receiving continuous renal replacement therapy originate from studies with relatively…”
Get full text

Levels of protein C and soluble thrombomodulin in critically ill patients with acute kidney injury: a multicenter prospective observational study by Bouchard, Josée, Malhotra, Rakesh, Shah, Shamik, Kao, Yu-Ting, Vaida, Florin, Gupta, Akanksha, Berg, David T, Grinnell, Brian W, Stofan, Brenda, Tolwani, Ashita J, Mehta, Ravindra L

“…Endothelial dysfunction contributes to the development of acute kidney injury (AKI) in animal models of ischemia reperfusion injury and sepsis. There are…”
Get full text

A Practical Citrate Anticoagulation Continuous Venovenous Hemodiafiltration Protocol for Metabolic Control and High Solute Clearance by Tolwani, Ashita J, Prendergast, Mary B, Speer, Rajesh R, Stofan, Brenda S, Wille, Keith M

“…Obstacles to the widespread use of continuous renal replacement therapy (CRRT) include the need for anticoagulation, customized solutions, and complex…”
Get full text

Practice Variation in the Prescription of Volume Removal with Acute KRT: A Call for Randomized Controlled Trials by Teixeira, J Pedro, Tolwani, Ashita J

Get full text

Debate: Intermittent Hemodialysis versus Continuous Kidney Replacement Therapy in the Critically Ill Patient: The Argument for CKRT by Bagshaw, Sean M, Neyra, Javier A, Tolwani, Ashita J, Wald, Ron

“…Continuous kidney replacement therapy (CKRT) is well entrenched as one of the dominant KRT modalities in modern critical care practice. Since its introduction…”
Get full text

A Quality Improvement Initiative Targeting CRRT Delivered Dose: The What, the How, and the Why by Neyra, Javier A., Tolwani, Ashita J.

Get full text

Timing of Renal Replacement Therapy for Acute Kidney Injury by Karakala, Nithin, Tolwani, Ashita J.

“…Acute kidney injury (AKI) is common in critically ill patients and associated with increased morbidity and mortality. With the increased use of renal…”
Get full text

Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury by Bagshaw, Sean M., Darmon, Michael, Ostermann, Marlies, Finkelstein, Fredric O., Wald, Ron, Tolwani, Ashita J., Goldstein, Stuart L., Gattas, David J., Uchino, Shigehiko, Hoste, Eric A., Gaudry, Stephane

“…Acute kidney injury (AKI) is associated with incremental risk for death and chronic kidney disease and represents a mounting clinical challenge for healthcare…”
Get full text

Simplified citrate anticoagulation for continuous renal replacement therapy by Tolwani, Ashita J., Campbell, Ruth C., Schenk, Margaret B., Allon, Michael, Warnock, David G.

“…Simplified citrate anticoagulation for continuous renal replacement therapy. Regional anticoagulation with trisodium citrate is an effective form of…”
Get full text

Standard versus High-Dose CVVHDF for ICU-Related Acute Renal Failure by TOLWANI, Ashita J, CAMPBELL, Ruth C, STOFAN, Brenda S, LAI, K. Robin, OSTER, Robert A, WILLE, Keith M

“…The effect of dosage of continuous venovenous hemodiafiltration (CVVHDF) on survival in patients with acute renal failure (ARF) is unknown. In this study, 200…”
Get full text

A patient with AKI after cardiac surgery by Tolwani, Ashita J

“…Up to 30% of patients undergoing cardiac surgery develop AKI, with 1% requiring RRT. AKI is an independent risk factor for morbidity and mortality…”
Get full text

Evaluation of Clinical and Machine Data of Critically Ill Adult COVID Patients with Acute Kidney Injury Exposed to Enhanced Hemoadsorption during CRRT by Cama-Olivares, Augusto, Ortiz-Soriano, Victor, Liu, Lucas J, Carter, Stuart, Takeuchi, Tomonori, Chen, Jin, Tolwani, Ashita J, Neyra, Javier A

“…The FDA authorized the emergency use of enhanced hemoadsorption with oXiris in critically ill adult COVID patients with respiratory failure or severe disease…”
Get more information

Critical care nephrology: management of acid-base disorders with CRRT by Cerdá, Jorge, Tolwani, Ashita J, Warnock, David G

“…Normal acid-base homeostasis is severely challenged in the intensive care setting. In this review, we address acid-base disturbances, with a special focus on…”
Get more information

A Monte Carlo Simulation Approach for Beta‐Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy by Jang, Soo Min, Gharibian, Katherine N., Lewis, Susan J., Fissell, William H., Tolwani, Ashita J., Mueller, Bruce A.

“…Cefepime, ceftazidime, and piperacillin/tazobactam are commonly used beta‐lactam antibiotics in the critical care setting. For critically ill patients…”
Get full text